Author

S. Meloche

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 3 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell signaling & trafficking· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:proteomics· 2 Organism:C. elegans· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

A. Kotlyarov· 2 shared M. Gaestel· 2 shared M. Soulez· 2 shared A. Doerrie· 1 shared B. G. Allen· 1 shared C. Crist· 1 shared C. Le Gouill· 1 shared C. Tesniere· 1 shared

Activity by Year

2021-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Kotlyarov

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

ERK3 Is Involved in Regulating Cardiac Fibroblast Function

P. Sahadevan, D. Dingar, S. A. Nawaito, R. S. Nair, J. Trepanier, F. Sahmi, Y. Shi, M.-A. Gillis, M. G. Sirois, S. Meloche, J.-C. Tardif, B. G. Allen

This study shows ERK3 regulates cardiac fibroblast function by affecting collagen production and motility in response to TGF-β and TAC.

bioRxiv · Dec 5, 2023Cell Biology

OSGN-1 is a conserved flavin-containing monooxygenase required to stabilize the intercellular bridge in late cytokinesis

E. Goupil, L. Lacroix, J. Briere, S. Guga, M. K. Saba-El-Leil, S. Meloche, J.-C. Labbe

This study identifies OSGN-1 as a conserved flavin-containing monooxygenase that stabilizes the intercellular bridge during late cytokinesis in C. elegans and human cells.

bioRxiv · Aug 6, 2023Cell Biology

The G protein-coupled receptor TBXA2R activates ERMs to control cell motility and invasion of triple-negative breast cancer cells.

K. Leguay, O. Naffati, Y. Y. He, M. Rogue, C. Tesniere, M. Gombos, H. Kuasne, L. Gaboury, C. Le Gouill, S. Meloche, M. Bouvier, S. Carreno

bioRxiv · Mar 28, 2023 · PreprintCancer Biology

On the therapeutic potential of MAPK4 in triple-negative breast cancer

F. Boudghene-Stambouli, M. Soulez, N. Ronkina, A. Doerrie, A. Kotlyarov, O.-M. Seternes, M. Gaestel, S. Meloche

The paper critiques Wang et al.'s study on ERK4's role in TNBC, arguing that methodological flaws undermine their conclusion that ERK4 is a therapeutic target.

bioRxiv · Aug 24, 2022 · PreprintCancer Biology

ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation

M. Soulez, P.-L. Tanguay, F. Do, C. Crist, J. Dort, A. Kotlyarov, M. Gaestel, N. A. Dumont, S. Meloche

bioRxiv · Apr 29, 2021Cell Biology